
Facilitating Partnership Explorations between a Pharma and a Digital Mental Health Company to Enable Patient-Centric and Holistic Care
AT GLANCE
The Story
The Global Digital Innovation team of a biopharmaceutical company was exploring a partnership with a digital mental health community platform. They faced complexity in defining the value this digital platform could offer due to varying objectives across different departments in the organization and the diverse range of services provided by the digital health company. Furthermore, they were uncertain about where to implement this solution within their organization.
The Ask
The client engaged Decimal.health to facilitate their partnership exploration, capitalizing on our profound expertise in the digital health market. They posed three essential questions:
- How can we shape the partnership to align with the pharma company's objectives and timelines?
- What are the digital health company's capabilities to fulfill these objectives?
- What would an engagement model look like, and where to land the solution in the organization?
THE APPROACH
As a first priority, Decimal.health assisted the client in preparing for discussions with the digital health partner and various internal departments, ensuring they came in well-informed. We equipped them with industry benchmarks for reference and key questions to ask.
In this phase, our client gained a clearer understanding of the objectives of the commercial and patient support teams within their organization, enabling them to engage in focused conversations with the digital health platform company.
Following the market analysis, we interviewed expert stakeholders to determine the need for the product, the feasibility of launch in the applicable care setting, and the likelihood of reaching client goals. With a thorough understanding of these factors, we were able to recommend an ideal use case and care setting that matched market and client needs.
In the subsequent phase, we formulated various partnership engagement scenarios, which further informed the deal-shaping conversations.
RESULTS
The pharmaceutical client had a clear understanding of potential collaboration avenues with the digital health company, including tangible stage-gated milestones and metrics.
As we take our clients’ confidentiality seriously, we are unable to provide further details. Typically, however, we observe that pharmaceutical companies internally assign partnership owners based on the value and risk associated with the digital health solution for the pharmaceutical company.
THE TEAM

